BIOMAT Database Logo BIOMAT Database Logo

Circulating placental protein 14: in the first trimester of spontaneous and IVF pregnancies. 1993

M R Johnson, and A Abbas, and J Q Norman-Taylor, and A F Riddle, and J G Grudzinskas, and T Chard, and K H Nicolaides
Neuroendocrinology Unit, Charing Cross and Westminster Medical School, Charing Cross Hospital, London, UK.

Circulating placental protein 14 (PP14) levels were measured during the first trimester in three groups of pregnant women: (i) natural conception (n = 15); (ii) pituitary desensitization with buserelin and ovarian stimulation with human menopausal gonadotrophin (HMG) followed by in-vitro fertilization and embryo transfer (IVF-ET) (n = 15); and (iii) ovarian stimulation with clomiphene citrate and HMG, followed by IVF-ET (n = 16). A 7- to 8-fold increase in serum PP14 levels was observed in normal pregnancies between weeks 4 and 10. This increase was earlier and less marked in group (ii) and absent in group (iii). These findings support the concept that endometrial function is altered in pregnancies achieved following ovarian stimulation. Alternatively, if the ovary is an important source of PP14, then these data suggest that in contrast to ovarian synthesis of steroids and the peptide relaxin, ovarian stimulation results in an impairment of PP14 synthesis, and that this is most marked when clomiphene citrate has been used.

UI MeSH Term Description Entries
D008596 Menotropins Extracts of urine from menopausal women that contain high concentrations of pituitary gonadotropins, FOLLICLE STIMULATING HORMONE and LUTEINIZING HORMONE. Menotropins are used to treat infertility. The FSH:LH ratio and degree of purity vary in different preparations. Gonadotropins, Human Menopausal,Human Menopausal Gonadotropin,CP-89044,CP-90033,HMG Ferring,HMG Lepori,HMG Massone,Humegon,Menogon,Menopur,Menotrophin,Normegon,ORG-31338,Pergonal,Pergonal-500,CP 89044,CP 90033,CP89044,CP90033,Gonadotropin, Human Menopausal,Human Menopausal Gonadotropins,Lepori, HMG,Menopausal Gonadotropin, Human,ORG 31338,ORG31338,Pergonal 500,Pergonal500
D010062 Ovulation Induction Techniques for the artifical induction of ovulation, the rupture of the follicle and release of the ovum. Ovarian Stimulation,Ovarian Stimulations,Stimulation, Ovarian,Stimulations, Ovarian
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011257 Pregnancy Proteins Proteins produced by organs of the mother or the PLACENTA during PREGNANCY. These proteins may be pregnancy-specific (present only during pregnancy) or pregnancy-associated (present during pregnancy or under other conditions such as hormone therapy or certain malignancies.) Placental Proteins,Proteins, Placental,Proteins, Pregnancy
D011261 Pregnancy Trimester, First The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation. Early Placental Phase,Pregnancy, First Trimester,Trimester, First,Early Placental Phases,First Pregnancy Trimester,First Pregnancy Trimesters,First Trimester,First Trimester Pregnancies,First Trimester Pregnancy,First Trimesters,Phase, Early Placental,Phases, Early Placental,Placental Phase, Early,Placental Phases, Early,Pregnancies, First Trimester,Pregnancy Trimesters, First,Trimesters, First
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002064 Buserelin A potent synthetic analog of GONADOTROPIN-RELEASING HORMONE with D-serine substitution at residue 6, glycine10 deletion, and other modifications. Bigonist,Buserelin Acetate,HOE-766,Profact,Receptal,Suprecur,Suprefact,Tiloryth,Acetate, Buserelin,HOE 766,HOE766
D002996 Clomiphene A triphenyl ethylene stilbene derivative which is an estrogen agonist or antagonist depending on the target tissue. Note that ENCLOMIPHENE and ZUCLOMIPHENE are the (E) and (Z) isomers of Clomiphene respectively. Chloramiphene,Clomifene,Clomid,Clomide,Clomifen,Clomiphene Citrate,Clomiphene Hydrochloride,Clostilbegit,Dyneric,Gravosan,Klostilbegit,Serophene,Citrate, Clomiphene,Hydrochloride, Clomiphene
D004624 Embryo Transfer The transfer of mammalian embryos from an in vivo or in vitro environment to a suitable host to improve pregnancy or gestational outcome in human or animal. In human fertility treatment programs, preimplantation embryos ranging from the 4-cell stage to the blastocyst stage are transferred to the uterine cavity between 3-5 days after FERTILIZATION IN VITRO. Blastocyst Transfer,Tubal Embryo Transfer,Tubal Embryo Stage Transfer,Embryo Transfers,Transfer, Embryo,Transfers, Embryo
D005260 Female Females

Related Publications

M R Johnson, and A Abbas, and J Q Norman-Taylor, and A F Riddle, and J G Grudzinskas, and T Chard, and K H Nicolaides
Serum placental protein 14 concentrations in the first trimester of ovum donation pregnancies.
March 1993, Human reproduction (Oxford, England),
M R Johnson, and A Abbas, and J Q Norman-Taylor, and A F Riddle, and J G Grudzinskas, and T Chard, and K H Nicolaides
First trimester trophoblast and placental bed vascular volume measurements in IVF or IVF/ICSI pregnancies.
December 2014, Human reproduction (Oxford, England),
M R Johnson, and A Abbas, and J Q Norman-Taylor, and A F Riddle, and J G Grudzinskas, and T Chard, and K H Nicolaides
First trimester bleeding in clinical IVF pregnancies.
August 1988, Human reproduction (Oxford, England),
M R Johnson, and A Abbas, and J Q Norman-Taylor, and A F Riddle, and J G Grudzinskas, and T Chard, and K H Nicolaides
First trimester placental markers in oocyte donation pregnancies.
August 2015, Placenta,
M R Johnson, and A Abbas, and J Q Norman-Taylor, and A F Riddle, and J G Grudzinskas, and T Chard, and K H Nicolaides
Circulating levels of placental protein 14 and progesterone following Mifepristone (RU38486) and Gemeprost for termination of first trimester pregnancy.
July 1989, Fertility and sterility,
M R Johnson, and A Abbas, and J Q Norman-Taylor, and A F Riddle, and J G Grudzinskas, and T Chard, and K H Nicolaides
Circulating levels of placental protein 12 in complications of first trimester pregnancy.
January 1989, Archives of gynecology and obstetrics,
M R Johnson, and A Abbas, and J Q Norman-Taylor, and A F Riddle, and J G Grudzinskas, and T Chard, and K H Nicolaides
First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes.
February 2008, Prenatal diagnosis,
M R Johnson, and A Abbas, and J Q Norman-Taylor, and A F Riddle, and J G Grudzinskas, and T Chard, and K H Nicolaides
First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome.
July 1992, BMJ (Clinical research ed.),
M R Johnson, and A Abbas, and J Q Norman-Taylor, and A F Riddle, and J G Grudzinskas, and T Chard, and K H Nicolaides
First-trimester screening markers are altered in pregnancies conceived after IVF/ICSI.
January 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology,
M R Johnson, and A Abbas, and J Q Norman-Taylor, and A F Riddle, and J G Grudzinskas, and T Chard, and K H Nicolaides
Comparison of second trimester uterine artery pulsatility index between IVF and spontaneous twin pregnancies.
January 2015, Clinical and experimental obstetrics & gynecology,
Copied contents to your clipboard!